Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age (from newborns to the elderly) who are not thought to have a rare disease and can provide a blood spot sample from routine newborn screening (note: for newborns, only leftover blood spot samples are used — no urine sample is needed, and no consent form is required for this group)
- People of any age (from newborns to the elderly) who have been confirmed to have a genetic metabolic disease or another rare disease where a metabolic (body chemistry) problem is suspected, with genetic test results to confirm the diagnosis
- People of any age (from newborns to the elderly) who have been diagnosed with autism spectrum disorder, assessed using standard diagnostic guidelines
- People of any age (from newborns to the elderly) who are suspected of having a genetic metabolic disease or rare disease with a possible body chemistry problem, but whose genetic or laboratory test results are not yet complete or are inconclusive
Who may not be able to join:
- People for whom the necessary information needed to place them in the correct study group is missing or unavailable
- People (or their legal guardians) who have not signed the required consent form to participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joseph P Dewulf, M.D., Ph.D., Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phone: 02/7646836
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Uncover new biomarkers in dried blood spots and urines samples able to improve the diagnosis of rare diseases
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.